Linda P Gertie

Title: The Innovative Contributions of Linda P. Gertie

Introduction

Linda P. Gertie is a notable inventor based in Cinnaminson, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. Her work has the potential to enhance the efficacy and safety of drug delivery systems.

Latest Patents

Linda P. Gertie holds 1 patent for her invention titled "Controlled release formulation." This innovative pharmaceutical formulation is designed to achieve a zero-order release of active drugs, such as procainamide hydrochloride. The formulation is presented in the form of a coated tablet, which allows for the slow release of the medicament over a controlled period. The core of the tablet includes hydrocolloid gelling agents, non-swellable binders, inert fillers, lubricants, and optional anti-adherents. The coating consists of both hydrophobic and hydrophilic polymers, ensuring optimal performance.

Career Highlights

Gertie's career is marked by her dedication to advancing pharmaceutical technology. She has worked with E. R. Squibb Sons, Inc., where she has been able to apply her expertise in drug formulation. Her innovative approach has contributed to the development of more effective medication delivery systems.

Collaborations

Throughout her career, Linda has collaborated with esteemed colleagues, including Nemichand B. Jain and Edward M. Rudnic. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Linda P. Gertie's contributions to the field of pharmaceuticals through her controlled release formulation patent exemplify her commitment to improving drug delivery systems. Her work continues to influence the industry and enhance patient care.